Clinical Research Studies in Pickup Family Neurosciences Institute

Participation in research and clinical investigation is an important commitment of Pickup Family Neurosciences Institute in its mission to provide patients access to leading-edge management and treatment for neurological disorders.

Hoag’s sub-specialized team of neuroscientists are actively involved in research to discover new therapies, drugs and other medical advancements to better the lives of patients suffering from neurological conditions. Pickup Family Neurosciences Institute is currently accepting patients to participate in a number of clinical research trials.

We offer clinical research studies in the following neurosciences therapeutic areas:

Multiple Sclerosis

• (196-24) Master protocol of two independent, randomized, double-blind, Phase 3 studies comparing efficacy and safety of frexalimab (SAR441344) to teriflunomide in adult participants with relapsing forms of multiple sclerosis

Other

• (129-25) Treatment of Essential Tremor by Non-Invasive Nerve Stimulation

• (186-25) Feasibility of Using a Soft-Touch Electrode for Visual Pathway Monitoring During Neurosurgery

• (239-23) Evaluating the Functionality of a Low Intensity Cranial PEMF Device in Improving chemotherapy-Induced Peripheral Neuropathy Symptoms

Your participation in any trial is entirely voluntary. You may decide to withdraw at any time without losing the benefits of your standard medical care.

To learn more about available clinical trials, please contact us at 949-764-4577 or clinicalresearch@hoag.org.